Diadynamic Currents Perform on Par With TENS in Tibial Nerve Stimulation for OAB
A randomized trial in women with overactive bladder found no meaningful advantage for diadynamic currents over standard TENS when the two were delivered as part of transcutaneous posterior tibial nerve stimulation. Both approaches improved symptoms and quality of life over four weeks, but the between-group comparison stayed flat. The absence of separation matters because the study tested a real substitution question, not a theoretical one: whether a current type already familiar to physical therapists in pain care could also serve as a neuromodulatory option for bladder symptoms.
The trial enrolled adult female patients with overactive bladder and used a double-blind randomized design. Participants received eight tibial nerve stimulation sessions, delivered twice weekly over four weeks. One arm underwent TTNS with TENS, while the other received TTNS with diadynamic currents. Both groups also received conventional physical therapy, including Kegel and breathing exercises. The mean age of the sample was 59.75 years, placing the cohort squarely in the age range where urgency, nocturia, and urgency incontinence often erode sleep and daily function.
Symptom Scores Fell in Both Arms, but Neither Current Pulled Ahead
Pre- and post-intervention scores on the ICIQ-OAB and ICIQ-OAB QOL improved significantly in both groups. Those gains signal a clinically familiar pattern in conservative bladder care: neuromodulation combined with pelvic floor support can reduce urgency burden and make daily life more manageable, even over a short treatment window. The core physiologic target is the shared sacral circuitry between the tibial nerve and lower urinary tract, where electrical stimulation may dampen detrusor overactivity and reshape reflex signaling through S2-S4 pathways. In practical terms, a peripheral nerve placed at the ankle can influence a bladder that is behaving as if its braking system has been weakened.
The comparison between groups, however, showed no significant difference. The p-values for the two questionnaire-based comparisons were 0.87 and 0.95, leaving little room for a meaningful efficacy gap between the two waveforms in this setting. The data also did not show significant correlations between patient-related characteristics and improvement in outcomes. Age, height, weight, body mass index, disease duration, and predisposing disorders did not meaningfully track with response in the reported analysis.
One sentence captures the clinical signal: diadynamic currents did not outperform TENS.
Why the Physiology Could Favor Similar Outcomes
The similarity between the two stimulation strategies is plausible. TTNS depends less on the brand-name waveform than on whether stimulation reaches the tibial nerve with enough consistency to trigger neuromodulatory effects. TENS delivers a high-frequency bidirectional pulsed current, while diadynamic currents are low-frequency, unidirectional sinusoidal waves obtained by rectifying alternating current. In theory, diadynamic currents may offer smoother perception, lower sensory discomfort, and deeper penetration at certain settings, but the clinical endpoint here was bladder symptom control rather than perceived current quality. If both currents can drive the same tibial afferent pathway and modulate sacral reflexes, a similar outcome would not be surprising.
The investigators also place the study within the usual treatment ladder for overactive bladder. Pharmacologic therapy, behavioral measures, pelvic floor strengthening, biofeedback, and tibial nerve stimulation all sit before more invasive options such as Botox, sacral neuromodulation, or bladder procedures. In that framework, a technically simpler or more versatile current could matter if it preserves tolerability and availability. Yet the present results do not show superiority; they only suggest equivalence in short-course symptom control within the tested cohort.
What the Trial Adds to Conservative OAB Care
The trial was conducted as a double-blind randomized controlled study and was registered in the Clinical Trials Registry of India. Ethical approval was obtained before enrollment. The sample size was small, with 20 participants per group, and the intervention window was brief, so the findings should be read as an early comparison rather than a definitive practice-shaping verdict. Even so, the signal is useful. For women already receiving conservative management, eight sessions of tibial nerve stimulation paired with home-style physical therapy produced measurable improvement in symptom burden and quality of life, regardless of whether the current source was TENS or diadynamic current.
That result gives clinicians a narrow but practical message: when TTNS is available, the choice between these two currents may come down more to equipment access, therapist familiarity, and patient comfort than to expected differences in efficacy. The study does not establish long-term durability, does not address recurrence after treatment ends, and does not prove noninferiority in a formal regulatory sense. It does show that the bladder response did not discriminate between the two current types over four weeks.
For a syndrome defined by urgency, frequency, nocturia, and urge incontinence, even modest short-term relief can alter sleep, mobility, and social confidence. The unanswered questions are more demanding now than before: whether the effect persists, whether repeated courses maintain benefit, and whether specific subgroups respond differently when stimulation parameters or waveform characteristics change. Those answers will require longer follow-up and larger samples than this trial provided.